|
|
Blood, 1 January 2006, Vol. 107, No. 1, pp. 241-249.
Prepublished online as a Blood First Edition Paper on September 1, 2005; DOI 10.1182/blood-2005-06-2409.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress
Ning Gao,
Mohamed Rahmani,
Xianglin Shi,
Paul Dent, and
Steven Grant
From the Departments of Medicine, Biochemistry, Pharmacology, and Radiation Oncology, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA; and Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV.
Interactions between the endogenous estradiol metabolite 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors (HDACIs) have been investigated in human leukemia cells. Coadministration of subtoxic or marginally toxic concentrations of 2-ME and SAHA or sodium butyrate in diverse human leukemia-cell types resulted in a marked increase in oxidative damage (eg, generation of reactive oxygen species [ROSs]), mitochondrial injury (eg, cytochrome c release and Bax translocation), caspase activation, and apoptosis. These interactions were also noted in primary human leukemia cells but not in normal bone marrow CD34+ cells. Synergistic interactions between these agents were associated with inactivation of Akt and activation of c-Jun N-terminal kinase (JNK). Essentially all of these events were reversed by free radical scavengers such as the manganese superoxide dismutase (MnSOD) mimetic TBAP and catalase. Notably, treatment with 2-ME/HDACIs resulted in down-regulation of thioredoxin, MnSOD, and glutathione peroxidase. Enforced activation of Akt blocked 2-ME/HDACI-mediated mitochondrial injury, caspase activation, and JNK up-regulation, but not generation of ROSs. Pharmacologic or genetic (siRNA) interruption of the JNK pathway also significantly attenuated the lethality of this regimen. Together, these findings support a model in which antileukemic synergism between 2-ME and HDACIs stems primarily from induction of oxidative damage, leading in turn to Akt inactivation and JNK activation, culminating in mitochondrial injury and apoptosis. They also raise the possibility that these events may preferentially occur in leukemic versus normal hematopoietic cells.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
ROS `n' roll: a bunch of JNK?
- Steven D. Gore
Blood 2006 107: 9-10.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K. J. Aiken, J. S. Bickford, M. S. Kilberg, and H. S. Nick
Metabolic Regulation of Manganese Superoxide Dismutase Expression via Essential Amino Acid Deprivation
J. Biol. Chem.,
April 18, 2008;
283(16):
10252 - 10263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. R. Fantin and V. M. Richon
Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications
Clin. Cancer Res.,
December 15, 2007;
13(24):
7237 - 7242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Manuguerra, G. Matullo, F. Veglia, H. Autrup, A.M. Dunning, S. Garte, E. Gormally, C. Malaveille, S. Guarrera, S. Polidoro, et al.
Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions
Carcinogenesis,
February 1, 2007;
28(2):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Wang, M. M. Zeigler, G. K. Lam, M. G. Hunter, T. D. Eubank, V. V. Khramtsov, S. Tridandapani, C. K. Sen, and C. B. Marsh
The Role of the NADPH Oxidase Complex, p38 MAPK, and Akt in Regulating Human Monocyte/Macrophage Survival
Am. J. Respir. Cell Mol. Biol.,
January 1, 2007;
36(1):
68 - 77.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. B. Arnold, N. Arkus, J. Gunn, and M. Korc
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Growth Inhibition and Enhances Gemcitabine-Induced Cell Death in Pancreatic Cancer
Clin. Cancer Res.,
January 1, 2007;
13(1):
18 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. T. Luong, J. O'Kelly, G. D. Braunstein, J. M. Hershman, and H. P. Koeffler
Antitumor Activity of Suberoylanilide Hydroxamic Acid against Thyroid Cancer Cell Lines In vitro and In vivo.
Clin. Cancer Res.,
September 15, 2006;
12(18):
5570 - 5577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Grant
Nuclear Acetylation Targets: NF-{kappa}B and the ROS Connection
Am. Assoc. Cancer Res. Educ. Book,
April 1, 2006;
2006(1):
322 - 326.
[Full Text]
[PDF]
|
|
|
| |
